<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.3-a.7'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//medicinacardiometabolica.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/03/easd-2026-diabetes-tipo-2-retatrutida-eloralintida-cagrisema/</loc>
  <lastmod>2026-10-03T11:10:51Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Diabetes tipo 2 2026 EASD: retatrutida, eloralintida y CagriSema con dosis, magnitud de efecto y qué prescribir hoy</news:title>
   <news:publication_date>2026-10-03T11:10:51Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/02/clics-eyeccion-clic-mesosistolico/</loc>
  <lastmod>2026-10-02T22:12:47Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Clics de eyección y clic mesosistólico: técnica y LR</news:title>
   <news:publication_date>2026-10-02T22:12:47Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/02/mcm-senalizacion-insulina-pi3k-akt-mapk-dia-2/</loc>
  <lastmod>2026-10-02T20:20:47Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Señalización de la insulina: PI3K-Akt frente a MAP-cinasas &amp;#124; Medicina Cardiometabólica · Día 2</news:title>
   <news:publication_date>2026-10-02T20:20:47Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/02/endo-neurohormonas-hipotalamicas-gnrh-trh-crh-ghrh-dia-2/</loc>
  <lastmod>2026-10-02T20:17:36Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Neurohormonas hipotalámicas GnRH, TRH, CRH y GHRH &amp;#124; Endocrinología · Día 2</news:title>
   <news:publication_date>2026-10-02T20:17:30Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/02/cardio-sistema-conduccion-nodo-sinusal-av-his-dia-2/</loc>
  <lastmod>2026-10-02T20:14:20Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Sistema de conducción cardiaco: nodo sinusal, nodo AV y haz de His &amp;#124; Cardiología · Día 2</news:title>
   <news:publication_date>2026-10-02T20:14:20Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/02/mi-semiologia-del-dolor-dia-2/</loc>
  <lastmod>2026-10-02T20:11:27Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Semiología del dolor: localización, irradiación, calidad e intensidad &amp;#124; Medicina Interna · Día 2</news:title>
   <news:publication_date>2026-10-02T20:11:27Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/02/eeuu-275-fluoxetina-para-que-sirve/</loc>
  <lastmod>2026-10-02T16:22:15Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Fluoxetina (Prozac): para qué sirve, dosis, efectos secundarios y precio (2026)</news:title>
   <news:publication_date>2026-10-02T16:22:15Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/02/orforglipron-achieve-4-glp1-oral-diabetes-tipo-2-2026/</loc>
  <lastmod>2026-10-02T11:12:05Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Diabetes tipo 2 2026: orforglipron (GLP-1 oral) no inferior a insulina glargina en MACE y −8,8 % de peso en ACHIEVE-4</news:title>
   <news:publication_date>2026-10-02T11:12:05Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/01/chasquido-apertura-estenosis-mitral/</loc>
  <lastmod>2026-10-01T22:13:47Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Chasquido de apertura: clave de la estenosis mitral</news:title>
   <news:publication_date>2026-10-01T22:13:47Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/01/eeuu-274-retiro-clortalidona-ramipril/</loc>
  <lastmod>2026-10-01T16:20:25Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Retiro de clortalidona 25 mg y ramipril 10 mg: lotes afectados, qué hacer y precios (2026)</news:title>
   <news:publication_date>2026-10-01T16:20:25Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/01/mcm-resistencia-insulina-definicion-mecanismos-dia-1/</loc>
  <lastmod>2026-10-02T20:56:24Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Resistencia a la insulina: definición y mecanismos celulares &amp;#124; Medicina Cardiometabólica · Día 1</news:title>
   <news:publication_date>2026-10-01T13:15:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/01/endo-eje-hipotalamo-hipofisis-retroalimentacion-dia-1/</loc>
  <lastmod>2026-10-02T20:56:08Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Eje hipotálamo-hipófisis y retroalimentación negativa y positiva &amp;#124; Endocrinología · Día 1</news:title>
   <news:publication_date>2026-10-01T13:10:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/01/cardio-cavidades-cardiacas-gasto-cardiaco-dia-1/</loc>
  <lastmod>2026-10-02T20:55:56Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Las cuatro cavidades cardiacas y el gasto cardiaco &amp;#124; Cardiología · Día 1</news:title>
   <news:publication_date>2026-10-01T13:05:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/01/anticoagulacion-fibrilacion-auricular-dialisis/</loc>
  <lastmod>2026-10-01T13:00:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Anticoagulación en FA y Diálisis 2026: ¿Apixabán o Nada?</news:title>
   <news:publication_date>2026-10-01T13:00:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/01/mi-anamnesis-sintoma-guia-dia-1/</loc>
  <lastmod>2026-10-01T13:00:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Anamnesis dirigida por síntoma guía: estructura y priorización &amp;#124; Medicina Interna · Día 1</news:title>
   <news:publication_date>2026-10-01T13:00:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://medicinacardiometabolica.com/2026/10/01/petrelintida-zupreme-1-obesidad-analogo-amilina-2026/</loc>
  <lastmod>2026-10-01T11:11:41Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Medicina Cardiometabólica</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Obesidad 2026: petrelintida (análogo de amilina) logra −10,7 % de peso a 42 semanas en ZUPREME-1 con 20 % de náusea</news:title>
   <news:publication_date>2026-10-01T11:11:41Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>